BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32494691)

  • 1. Surviving COVID-19: A disease tolerance perspective.
    Ayres JS
    Sci Adv; 2020 May; 6(18):eabc1518. PubMed ID: 32494691
    [No Abstract]   [Full Text] [Related]  

  • 2. Statin therapy and SAR-COV-2: an available and potential therapy?
    Abdel-Latif RG; Mohammed S; Elgendy IY
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307
    [No Abstract]   [Full Text] [Related]  

  • 3. Modeling infectious disease dynamics.
    Cobey S
    Science; 2020 May; 368(6492):713-714. PubMed ID: 32332062
    [No Abstract]   [Full Text] [Related]  

  • 4. [Not Available].
    Balavoine JF
    Rev Med Suisse; 2020 May; 16(695):1126. PubMed ID: 32462848
    [No Abstract]   [Full Text] [Related]  

  • 5. The 2019 human coronavirus: Ten areas of uncertainty waiting to be resolved.
    Mortimer PP
    Rev Med Virol; 2020 Jul; 30(4):e2114. PubMed ID: 32394505
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
    Catanzaro M; Fagiani F; Racchi M; Corsini E; Govoni S; Lanni C
    Signal Transduct Target Ther; 2020 May; 5(1):84. PubMed ID: 32467561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 with Pulmonary Involvement. An Autoimmune Disease of Known Cause.
    Fernandez-Gutierrez B
    Reumatol Clin (Engl Ed); 2020; 16(4):253-254. PubMed ID: 32345483
    [No Abstract]   [Full Text] [Related]  

  • 8. JAK Inhibition as a New Treatment Strategy for Patients with COVID-19.
    Seif F; Aazami H; Khoshmirsafa M; Kamali M; Mohsenzadegan M; Pornour M; Mansouri D
    Int Arch Allergy Immunol; 2020; 181(6):467-475. PubMed ID: 32392562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 positivity in a discharged COVID-19 patient: a case report.
    Li J; Long X; Fang X; Zhang Q; Hu S; Lin Z; Xiong N
    Clin Microbiol Infect; 2020 Aug; 26(8):1115-1117. PubMed ID: 32360448
    [No Abstract]   [Full Text] [Related]  

  • 10. Treating COVID-19 with colchicine in community healthcare setting.
    Della-Torre E; Della-Torre F; Kusanovic M; Scotti R; Ramirez GA; Dagna L; Tresoldi M
    Clin Immunol; 2020 Aug; 217():108490. PubMed ID: 32492478
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 serologic testing: FAQs and caveats.
    Kadkhoda K
    Cleve Clin J Med; 2020 Jun; 87(6):329-333. PubMed ID: 32434807
    [No Abstract]   [Full Text] [Related]  

  • 12. Audio Interview: Approaches to Covid-19 Vaccines and Antivirals.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Apr; 382(16):e58. PubMed ID: 32320592
    [No Abstract]   [Full Text] [Related]  

  • 13. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
    [No Abstract]   [Full Text] [Related]  

  • 14. Covid-19 management with inflammation resolving mediators? Perspectives and potential.
    Regidor PA
    Med Hypotheses; 2020 Sep; 142():109813. PubMed ID: 32416413
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
    Abid MB; Mughal M; Abid MA
    JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
    [No Abstract]   [Full Text] [Related]  

  • 16. A Comprehensive Updated Review on SARS-CoV-2 and COVID-19.
    Ren YR; Golding A; Sorbello A; Ji P; Chen J; Saluja B; Witzmann K; Arya V; Reynolds KS; Choi SY; Nikolov NP; Sahajwalla C
    J Clin Pharmacol; 2020 Aug; 60(8):954-975. PubMed ID: 32469437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies.
    Bergmann CC; Silverman RH
    Cleve Clin J Med; 2020 Jun; 87(6):321-327. PubMed ID: 32366502
    [No Abstract]   [Full Text] [Related]  

  • 18. Type 1 interferons as a potential treatment against COVID-19.
    Sallard E; Lescure FX; Yazdanpanah Y; Mentre F; Peiffer-Smadja N
    Antiviral Res; 2020 Jun; 178():104791. PubMed ID: 32275914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between SARS-CoV-2 and the type I interferon response.
    Sa Ribero M; Jouvenet N; Dreux M; Nisole S
    PLoS Pathog; 2020 Jul; 16(7):e1008737. PubMed ID: 32726355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.
    Omarjee L; Janin A; Perrot F; Laviolle B; Meilhac O; Mahe G
    Clin Immunol; 2020 Jul; 216():108464. PubMed ID: 32405269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.